NEW YORK (GenomeWeb News) – Exiqon will seek microRNA biomarkers for breast cancer through a collaboration with the University of Texas MD Anderson Cancer Center, the company said today.
 
Under the collaboration, the Danish company Exiqon will use its miRCURY LNA locked nucleic acid nucleotide products to discover microRNA biomarkers for the Kleberg Center for Molecular Markers at the cancer center.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.